Secondary breast angiosarcoma and germ line BRCA mutations: discussion of genetic susceptibility

Mark R, Joseph PC, Tran LM, Fu YS, Juillard GF (1996) Angiosarcoma: a report of 67 patients and review of the literature. Cancer 77:2400–2406

Hodgson NC, Bowen-Wells C, Moffat F, Franceschi D, Avisar E (2007) Angiosarcomas of the breast: a review of 70 cases. American Journal of Clinical Oncology 30:570–573

Chen KT, Kirkegaard DD, Bocian JJ (1980) Angiosarcoma of the breast. Cancer 46:368–371

Glazebrook KN, Magut MJ, Reynolds C (2008) Angiosarcoma of the breast. Am J Roentgenology 190:533–538

Brenn T, Fletcher CD (2006) Postradiation vascular proliferations: an increasing problem. Histopathology 48:106–114

Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97:1832–1840

West JG, Qureshi A, West JE et al (2005) Risk of angiosarcoma following breast conservation: a clinical alert. The Breast Journal 11:115–123

Meek A (1998) Breast radiotherapy and lymphedema. Cancer 83:2788–2797

West JG, Weitzel JN, Tao ML et al (2008) BRCA mutations and the risk of angiosarcoma after breast cancer treatment. Clinical Breast Cancer 8:533–537

Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ (2010) Angiosarcoma. Lancet Oncol 11:983–991

Bermejo JL, Hemminki K (2004) Risk of cancer at sites other than breast in Swedish families eligible for BRCA 1 or BRCA 2 mutation testing. Annals of Oncology 15:1834–41

Wooster R, Weber BL (2003) Breast and ovarian cancer. New England Journal of Medicine 348:2339–2347

Manoukian S, Peissel B, Pensotti V et al (2007) Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. European Journal of Cancer 42:601–606

Lynch HT, Deters CA, Hogg D et al (2003) Familial sarcoma: challenging pedigrees. Cancer 98:1947–1957

Benson JR, Osborne MP (1999) Letter to the editor. Breast Cancer Research and Treatment 55:293

Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182

Snouwaert JN, Gowen LC, Latour AM et al (1999) BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 18:7900–7907

Tutt A, Bertwistle D, Valentine J et al (2001) Mutation in BRCA2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J 20:4704–4716

Xia F, Taghian DG, DeFrank JS et al (2001) Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci USA 98:8644–8649

Powell SN, Kachni LA (2003) Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 22:578–5791

Shen SX, Weaver Z, Xu X et al (1998) A targeted disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17:3115–3124

Sharan SK, Morimatsu M, Albrecht U et al (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386:804–810

Tutt ANJ, van Oostrom CTM, Ross GM, van Steeg H, Ashworth A (2002) Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO Rep 15:255–260

Buchholz TA, Wu X, Hussain A et al (2001) Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. International Journal of Cancer 97:557–561

Trenz K, Rothfuss A, Schütz P et al (2002) Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutation Research 500:89–96

Jeng YM, Cai-Ng S, Li A et al (2007) BRCA1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation. Oncogene 26:6160–6166

Andrieu N, Easton DF, Chang-Claude J et al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, CEO-HEBON, and IBCCS collaborators’ group. J Clin Oncol 24:3361–3366

Tahir M, Hendry P, Baird L et al (2006) Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. Int Semin Surg Oncol 3:26

Kuttesch JF Jr, Wexler LH, Marcus RB et al (1996) Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 14:2818–2825

Cahan WG, Woodward HQ, Higinbotham NL et al (1948) Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1:3–29

Feigenberg SJ, Mendenhall NP, Reith JD et al (2002) Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy. Int J Rad Oncol Biol Phys 52:620–626

Palta M, Morris CG, Grobmyer SR et al (2002) Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer 116:1872–1878

Abbott R, Palmieri C (2008) Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. Nature Clinical Practice Oncology 5:727–736

Foray N, Randrianarison V, Marot D et al (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18:7334–7342

Pierce LJ, Strawderman M, Narod SA et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. Journal of Clinical Oncology 18:3360–3369

Leong T, Whitty J, Keilar M et al (2000) Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys 48:959–965

Gaffney DK, Brohet RM, Lewis CM et al (1998) Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol 47:129–136